'Serum markers' presentation slideshows

536 views • 42 slides

919 views • 22 slides

Mitchell W. Krucoff, C.K. Ponde, Jagdish Hiremath, Mullasari Ajit,

A Prospective Randomized Trial of CMX-2043, a Lipoic Acid-Based Cytoprotectant , In Patients Undergoing Elective PCI: Primary Results of the SUPPORT-1 Trial. Mitchell W. Krucoff, C.K. Ponde, Jagdish Hiremath, Mullasari Ajit, Eddison Ramsaran, Manesh R. Patel, Alan S. Lader,

348 views • 20 slides

Non invasive markers of liver fibrosis

Non invasive markers of liver fibrosis. Fibrotest and ELF By Taher ELZANATY, MD. Population at risk of liver fibrosis , cirrhosis and hepatocellular carcinoma (Millions). Only 5% of patients at risk of fibrosis do have a liver biopsy.

949 views • 16 slides

Biochemistry of Hepatitis C

Biochemistry of Hepatitis C. Daye Jeong Joo-Oll Kim Ginyoung Lee Julia Wong. PHM142 Fall 2013 Coordinator: Dr. Jeffrey Henderson Instructor: Dr. David Hampson. Outline. Introduction to Hepatitis C What is Hepatitis C? Transmission Symptoms Testing

359 views • 12 slides

PATIENTS:

SERUM CONCENTRATION OF ACE, NEOPTERIN, TNF-? AND SIL-2R IN HEALTHY WORKERS EXPOSED TO DIFFERENT METAL DUSTS Harald C Ott, Christian Prior, Manfred Herold, Markus Riha, Guenter Ott Department of Cardiac Surgery, Department of Medicine, University Hospital Innsbruck. INTRODUCTION:

99 views • 1 slides